Clinical Trial: A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07481708) titled 'A Clinical Study of the Effect of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-041)' on March 16.

Brief Summary: The goal of this study is to learn what happens to enlicitide (MK-0616) in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of enlicitide and if people tolerate it.

Study Start Date: March 16

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Enlicitide

Oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Curated by HT Syndication....